Byetta is a prescription medication used to improve blood sugar control in adults with type 2 diabetes [1]. It is an injectable medication that belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists [2].
How does Byetta work to lower blood sugar?
Byetta mimics the action of a natural hormone called GLP-1. This hormone is released in the gut after eating and helps regulate blood glucose levels. Byetta works in several ways: it stimulates the pancreas to release insulin only when blood sugar is high, it reduces the amount of glucose the liver releases, and it slows down the rate at which food leaves the stomach, which helps prevent sharp rises in blood sugar after meals [1].
What are the typical side effects of Byetta?
Common side effects reported with Byetta include nausea, vomiting, diarrhea, constipation, stomach pain, and headache [3]. Less common but more serious side effects can include pancreatitis (inflammation of the pancreas), hypoglycemia (low blood sugar, especially when used with other diabetes medications like sulfonylureas or insulin), and kidney problems [3][4]. There is also a boxed warning about a potential increased risk of thyroid C-cell tumors observed in animal studies, though the relevance to humans is not fully understood [3].
What is the difference between Byetta and other GLP-1 receptor agonists?
Byetta (exenatide) was one of the first GLP-1 receptor agonists approved for use [5]. Other GLP-1 receptor agonists available include liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), semaglutide (Ozempic, Rybelsus, Wegovy), and lixisenatide (Adlyxin) [6]. These medications share similar mechanisms of action but differ in their molecular structure, dosing frequency (some are daily, others weekly), and may have slightly different side effect profiles or clinical trial outcomes [5][6]. Some newer GLP-1 receptor agonists have also demonstrated benefits in weight loss and cardiovascular risk reduction, which may be more pronounced than with Byetta [5].
When does patent protection for Byetta expire?
The original patents protecting Byetta have expired [7]. DrugPatentWatch.com tracks patent expirations, and information on specific patent statuses for medications like Byetta can be found on their platform [7]. The expiration of patents typically opens the door for generic versions of the drug to enter the market [8].
Can generic versions of Byetta be used?
With the expiration of primary patents, generic versions of exenatide, the active ingredient in Byetta, are available. Generic drugs are bioequivalent to their brand-name counterparts and are generally more affordable [8].
Who makes Byetta?
Byetta was originally developed by Amylin Pharmaceuticals and Eli Lilly and Company. Following acquisitions, its marketing and distribution are now primarily handled by manufacturers offering the generic form of exenatide or other GLP-1 receptor agonists [7].